Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
Companies
» Company Monitoring Page for Merck
Company Monitoring Page for Merck
latest headlines for company on cafepharma
Merck's Keytruda hits overall survival goal in early lung cancer as FDA decision nears
Fierce Pharma
Tue, 10/10/23 - 10:18 am
Tags:
Merck
,
Keytruda
,
non-small cell lung cancer
Eikon cuts staff 'to become more efficient,' letter from CEO Perlmutter reveals
Fierce Biotech
Sun, 10/8/23 - 02:44 pm
Tags:
Eikon Therapeutics
,
Roger Perlmutter
,
Merck
,
layoffs
Merck eyes new bladder cancer space with positive Keytruda trial in muscle-invasive disease
Fierce Pharma
Thu, 10/5/23 - 09:03 pm
Tags:
Merck
,
Keytruda
,
bladder cancer
,
muscle-invasive urothelial carcinoma
US plans shift of Merck COVID treatment to commercial market
Reuters
Thu, 10/5/23 - 10:16 am
Tags:
Merck
,
COVID-19
,
Lagevrio
,
molnupiravir
Sanofi pays Teva $500M to join Merck, Roivant in red-hot bowel disease race
Fierce Biotech
Wed, 10/4/23 - 09:48 am
Tags:
Sanofi
,
Teva Pharmaceutical
,
inflammatory bowl disease
,
IBD
,
Merck
,
Roivant
FDA gives Merck priority review for blood vessel disorder therapy sotatercept
Medical Marketing and Media
Thu, 09/28/23 - 11:42 pm
Tags:
Merck
,
PAH
,
sotatercept
,
FDA
Merck, Seagen and Astellas Get Late-Stage Win in Bladder Cancer with Combo
BioSpace
Fri, 09/22/23 - 11:53 am
Tags:
Merck
,
Seagen
,
Astellas
,
urothelial cancer
,
clinical trials
,
bladder cancer
,
Padcev
,
Keytruda
Merck and Eisai's Keytruda-Lenvima combo chalks up 2 more losses, this time in non-small cell lung cancer
Fierce Pharma
Fri, 09/22/23 - 11:46 am
Tags:
Merck
,
Eisai
,
Keytruda
,
Lenvima
,
melanoma
,
colorectal cancer
,
non-small cell lung cancer
Merck (MRK) Keytruda Cervical Cancer sBLA Gets FDA Priority Tag
Yahoo/Zacks.com
Thu, 09/21/23 - 06:32 pm
Tags:
Merck
,
Keytruda
,
FDA
,
cervical cancer
,
priority review
1ST Biotherapeutics and Merck to assess cancer combination treatment
Clinical Trials Arena
Wed, 09/20/23 - 11:09 pm
Tags:
Merck
,
1st Biotherapeutics
,
Keytruda
,
solid tumors
,
clinical trials
HHS argues Merck 'lacks standing' to sue over Medicare price negotiations
Fierce Pharma
Wed, 09/13/23 - 11:38 am
Tags:
Merck
,
Inflation Reduction Act
,
HHS
,
legal
Merck keeps pumping up sotatercept, posting fresh data ahead of FDA approval ruling
Fierce Biotech
Mon, 09/11/23 - 11:54 am
Tags:
Merck
,
sotatercept
,
FDA
,
cardiovascular disease
Patent cliffs, divestitures and maturing biotechs all point to more pharma M&A: analysts
Fierce Pharma
Fri, 09/8/23 - 10:29 am
Tags:
M&A
,
patent cliffs
,
Merck
,
JNJ
,
Pfizer
,
GSK
,
Novartis
,
Eli Lilly
,
Novo Nordisk
The 10 highest value R&D projects in biopharma
Fierce Biotech
Wed, 09/6/23 - 10:17 am
Tags:
R&D
,
biotech
,
Merck
,
sotatercept
,
Daiichi Sankyo
,
AstraZeneca
,
Dato-DXd
,
Novo Nordisk
,
CagriSema
,
Eli Lilly
,
donanemab
,
Karuna Therapeutics
,
Zai Lab
,
KarXT
,
Moderna Therapeutics
,
mRNA-1647
,
Novartis
,
iptacopan
,
Madrigal Pharmaceuticals
,
resmetirom
,
Cytokinetics
,
aficamten
,
Roche
,
Chugai
,
tiragolumab
5 of the best places to work in pharma, according to employees
Pharma Voice
Tue, 08/29/23 - 11:32 am
Tags:
Glassdoor
,
Merck
,
JNJ
,
Pfizer
,
GSK
,
Sanofi
Merck Initiates Phase 3 Clinical Program for Oral PCSK9 Inhibitor Candidate MK-0616
Drugs.com
Mon, 08/28/23 - 08:23 pm
Tags:
Merck
,
clinical trials
,
MK-0616
,
hypercholesterolemia
Merck, Eisai Drop Phase III Keytruda-Lenvima Trial for Head and Neck Cancer
BioSpace
Sun, 08/27/23 - 04:40 pm
Tags:
Merck
,
Eisai
,
Keytruda
,
Lenvima
,
clinical trials
,
head and neck cancer
Merck bets big on oral PCSK9 inhibitor, putting 6-year outcome study at heart of phase 3 program
Fierce Biotech
Fri, 08/25/23 - 09:57 am
Tags:
Merck
,
PCSK9 inhibitors
,
clinical trials
,
cardiovascular disease
,
cholesterol
,
MK-0616
Merck’s Keytruda to top drug sales in 2028, as Roche takes pharma crown
Medical Marketing and Media
Fri, 08/25/23 - 09:55 am
Tags:
Merck
,
Keytruda
,
Roche
,
branding
The Biopharma Patent Cliff: 9 Drugs Losing Exclusivity by the End of 2023
BioSpace
Wed, 08/23/23 - 11:11 am
Tags:
patent cliff
,
patents
,
Takeda
,
Vyvanse
,
Pfizer
,
Eraxis
,
JNJ
,
Stelara
,
Merck
,
Isentress
,
Eiger Pharmaceuticals
,
Zokinvy
,
Astellas
,
Myrbetriq
,
Novartis
,
Entresto
,
Amgen
,
Otzela
Pages
« first
‹ previous
1
2
3
4
5
6
7
8
9
…
next ›
last »
last 30 twitter posts
current feelings about your job
job rating
*
1 - I hate my job
2
3
4
5
6
7 - I love my job
Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
please tell us why
*
your industry
*
your job title (optional)
your company
*
published
N/A
published
not published
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
an umbrella protects you from: rain, sand, hunger
*
Fill in the blank.